Cargando…
247. Evaluation of the Efficacy and Safety of Cefazolin in Non-Pneumococci Streptococcal Bacteremia
BACKGROUND: Among the large variation of streptococcal infections, recommended therapies are generally well-defined. There is a lack of efficacy data on alternative therapies, notably in phylogenetic groups that are less studied. The purpose of this study is to quantify the differences in clinical e...
Autores principales: | Wibisono, Arya, Rose, Dusten T T, Jaso, Theresa (Terry) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677406/ http://dx.doi.org/10.1093/ofid/ofad500.320 |
Ejemplares similares
-
1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019) -
310. The Impact of Microscan versus Vitek-2 for Automated Susceptibility Testing on the Utilization of Vancomycin Alternatives for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Moskhos, Alexander, et al.
Publicado: (2020) -
185. Does an Infectious Diseases Consultation Improve Clinical Outcomes and Treatment Bundle Adherence for Enterococcal Bacteremia in a Multicenter Healthcare System?
por: Shephard, Emily A, et al.
Publicado: (2021) -
216. Are Automatic Antimicrobial Stop Orders an Effective Stewardship Tool for Urinary Tract and Intra-Abdominal Infections?
por: Maguire, Christina, et al.
Publicado: (2020) -
1801. Impact of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) on Clinical Outcomes in Patients with Gram Positive Blood Cultures in a Diverse, Multicenter Healthcare System With a Central Laboratory
por: Carr, Amy, et al.
Publicado: (2018)